Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
During this open label study patients will receive IMM-101 in conjunction with a recognised standard of care for metastatic or unresectable cancer for the patient's specific tumour type. The primary objective of the study is to provide safety data for IMM-101 in combination with a number of selected standard of care regimens.
Inclusion criteria
- Metastatic Cancer